Can Abatacept pass medical insurance reimbursement and guidance on the reimbursement process

Abatacept is a selective T cell costimulation modulator, mainly used to treat moderate to severe rheumatoid arthritis and some autoimmune diseases. The drug reduces inflammatory responses and joint destruction by inhibiting T cell activation, significantly improving patients' clinical symptoms and quality of life. Clinical studies have shown that abatacept has significant effects on improving joint pain, morning stiffness time and joint function scores, and is well tolerated.

In terms of medical insurance reimbursement, abatacept has not yet been included in the domestic medical insurance catalog. This means that domestic patients need to pay the full cost of the drug out of their own pocket when purchasing the drug. The price is approximately RMB 6,000 to 7,000. The specific selling price may vary in each region and hospital. Patients are advised to consult the local hospital pharmacy for the latest price information before taking the drug. Although the price of the drug is relatively high in China, it still attracts the attention of clinicians and patients due to its proven efficacy in treating moderate to severe rheumatoid arthritis and refractory autoimmune diseases.

For patients who want to be reimbursed through medical insurance, they can currently only apply through special medical assistance or self-pay reimbursement policies in individual places, but such cases are rare and not universal. If patients need to use abatacept, it is recommended to communicate with their doctor in detail about the treatment plan and decide whether to choose this drug based on their own financial situation. At the same time, you can also pay attention to the future adjustments to the medical insurance catalog. Once included in the medical insurance, patients will be able to enjoy partial expense reimbursement, thus reducing the financial burden.
In the international market, the price of abatacept is relatively low. For example, the price of the original drug in Türkiye is about more than 5,000 yuan. Each patient can choose the appropriate channel to purchase according to the doctor's prescription and his or her own conditions. Generally speaking, abatacept has not yet been reimbursed by medical insurance in China, but its clinical efficacy is obvious and is of great value to patients with severe rheumatoid arthritis. Before taking medication, patients should formulate a scientific and reasonable treatment plan based on their economic status, disease severity and doctor's advice.
Reference link: https://www.drugs.com